News Releases

Date Title View
Toggle Summary Aerie Pharmaceuticals to Announce First Quarter 2014 Financial Results and Host Conference Call on Monday, May 12, 2014
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced today that its first quarter 2014 financial results will be released after the market closes on Monday, May 12, 2014 .
View HTML
Toggle Summary Aerie Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido , Jr., Ph.D., chairman and chief executive officer, will present at the 13 th Annual Needham Healthcare Conference on Wednesday,
View HTML
Toggle Summary Aerie Pharmaceuticals Names Richard A. Lewis, M.D., as Chair of Scientific Advisory Board
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that
View HTML
Toggle Summary Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business and Product Development Update
Aerie on Track with Both Clinical Programs; Debuts Product Trade Names for Triple-Action and Quadruple-Action Candidates Conference Call and Webcast Today, March 18 , at 5:00 p.m. ET BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.
View HTML
Toggle Summary Aerie Pharmaceuticals to Announce Fourth Quarter and Year End 2013 Financial Results and Host Conference Call on Tuesday, March 18, 2014
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) announced today that its fourth quarter and year end 2013 financial results will be released after the market closes on Tuesday, March 18, 2014 .
View HTML
Toggle Summary Aerie Pharmaceuticals to Present at the 26th Annual ROTH Conference
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido , Jr., Ph.D., chairman and chief executive officer will present at the 26 th Annual ROTH Conference on Monday, March 10 th at
View HTML
Toggle Summary Aerie Pharmaceuticals to Present at the Cowen and Company 34th Annual Health Care Conference
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) today announced that the Company will present at the Cowen and Company 34 th Annual Health Care Conference on Tuesday, March 4 th at 10:40 a.m.
View HTML
Toggle Summary Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechanism of Action for Lead Glaucoma Drug Candidate AR-13324
AR-13324 Found to Lower Episcleral Venous Pressure (EVP) in Preclinical In Vivo Model, Providing Further Insight into Differentiated Efficacy Profile BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc.
View HTML
Toggle Summary Aerie Pharmaceuticals Names Marvin J. Garrett as Vice President, Regulatory Affairs and Quality Assurance
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that
View HTML
Toggle Summary Aerie Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference
BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif. --(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Vicente Anido , Jr., Ph.D., chairman and chief executive officer, will present in a fireside chat discussion at the RBC Capital Markets Global
View HTML